Succinate prodrugs for use in the treatment of lactic acidosis or drug-induced side-effects due to complex i-related impairment of mitochondrial oxidative phosphorylation
MA39857AUndetermined Publication Date: 2017-02-15NEUROVIVE PHARMA AB
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MA39857
- Authority / Receiving Office
- MA · MA
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2014-04-08
- Filing Date
- 2015-04-08
- Publication Date
- 2017-02-15
Abstract
The present invention relates to a succinate prodrug for use in the treatment or prevention of lactic acidosis.
Need to check novelty before this filing date? Find Prior Art